Literature DB >> 12624090

The C-terminal kinase domain of the p34cdc2-related PITSLRE protein kinase (p110C) associates with p21-activated kinase 1 and inhibits its activity during anoikis.

She Chen1, Xianglei Yin, Xiaoyu Zhu, Jun Yan, Shuying Ji, Chun Chen, Mingmei Cai, Songwen Zhang, Hongliang Zong, Yun Hu, Zhenghong Yuan, Zonghou Shen, Jianxin Gu.   

Abstract

The PITSLRE protein kinases are parts of the large family of p34cdc2-related kinases. During apoptosis induced by some stimuli, specific PITSLRE isoforms are cleaved by caspase to produce a protein that contains the C-terminal kinase domain of the PITSLRE proteins (p110C). The p110C induces apoptosis when it is ectopically expressed in Chinese hamster ovary cells. In our study, similar induction of this p110C was observed during anoikis in NIH3T3 cells. To investigate the molecular mechanism of apoptosis mediated by p110C, we used the yeast two-hybrid system to screen a human fetal liver cDNA library and identified p21-activated kinase 1 (PAK1) as an interacting partner of p110C. The association of p110C with PAK1 was further confirmed by in vitro binding assay, in vivo coimmunoprecipitation, and confocal microscope analysis. The interaction of p110C with PAK1 occurred within the residues 210-332 of PAK1. Neither association between p58PITSLRE or p110PITSLRE and PAK1 nor association between p110C and PAK2 or PAK3 was observed. Anoikis was increased and PAK1 activity was inhibited when NIH3T3 cells were transfected with p110C. Furthermore, the binding of p110C with PAK1 and inhibition of PAK1 activity were also observed during anoikis. Taken together, these data suggested that PAK1 might participate in the apoptotic pathway mediated by p110C.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12624090     DOI: 10.1074/jbc.M300818200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  BCL2L12A localizes to the cell nucleus and induces growth inhibition through G2/M arrest in CHO cells.

Authors:  Yi Hong; Junwu Yang; Yayun Chi; Wenzong Wang; Weibing Wu; Xiaojing Yun; Xiangfei Kong; Jianxin Gu
Journal:  Mol Cell Biochem       Date:  2010-01       Impact factor: 3.396

Review 2.  p21-Activated Kinases in Thyroid Cancer.

Authors:  Luis Bautista; Christina M Knippler; Matthew D Ringel
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

3.  Death-signal-induced relocalization of cyclin-dependent kinase 11 to mitochondria.

Authors:  Yongmei Feng; Maria E Ariza; Anne-Christine Goulet; Jiaqi Shi; Mark A Nelson
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

4.  Active p21-activated kinase 1 rescues MCF10A breast epithelial cells from undergoing anoikis.

Authors:  Raymond E Menard; Andrew P Jovanovski; Raymond R Mattingly
Journal:  Neoplasia       Date:  2005-07       Impact factor: 5.715

Review 5.  Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.

Authors:  Alan Hammer; Maria Diakonova
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

6.  Regulation of stability of cyclin-dependent kinase CDK11p110 and a caspase-processed form, CDK11p46, by Hsp90.

Authors:  Monika Mikolajczyk; Mark A Nelson
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

7.  De novo transcriptome sequencing analysis and comparison of differentially expressed genes (DEGs) in Macrobrachium rosenbergii in China.

Authors:  Hai Nguyen Thanh; Liangjie Zhao; Qigen Liu
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

8.  Critical role of CDK11(p58) in human breast cancer growth and angiogenesis.

Authors:  Yayun Chi; Sheng Huang; Haojie Peng; Mengying Liu; Jun Zhao; Zhiming Shao; Jiong Wu
Journal:  BMC Cancer       Date:  2015-10-15       Impact factor: 4.430

Review 9.  PAK signaling in oncogenesis.

Authors:  P R Molli; D Q Li; B W Murray; S K Rayala; R Kumar
Journal:  Oncogene       Date:  2009-05-25       Impact factor: 9.867

10.  Klotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinoma.

Authors:  Lin Chen; Haiou Liu; Jing Liu; Yu Zhu; Le Xu; Hongyong He; Heng Zhang; Shanshan Wang; Qian Wu; Weisi Liu; Yidong Liu; Deng Pan; Shifang Ren; Jiejie Xu; Jianxin Gu
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.